ZS Pharma's Series B - II Round

ZS Pharma raised a round of funding on July 10, 2012. Investors include Devon Park Bioventures.

ZS Pharma is a specialty pharmaceutical company focused on the development and commercialization of oral sorbent technology. The company's lead therapeutic candidate, ZS-9, is a novel treatment for hy…

Articles about ZS Pharma's Series B - II Round: